Kemula Pierre Thadee Victor
Chief Financial Officer
Kemula Pierre Thadee Victor has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Oct 7, 2026.
On the most recent filing, Kemula Pierre Thadee Victor is listed as Chief Financial Officer at AgomAb Therapeutics NV. Inside the rolling window, Kemula Pierre Thadee Victor reported 1 open-market purchase totaling $86K in AGMB and no open-market sales.
Companies traded
Other insiders at AGMB
Insider Buying
$86K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kemula Pierre Thadee Victor made?
Kemula Pierre Thadee Victor has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company since 2026.
Which companies does Kemula Pierre Thadee Victor trade?
Kemula Pierre Thadee Victor has filed SEC Form 4 disclosures for 1 company, including AGMB.
When was Kemula Pierre Thadee Victor's most recent SEC Form 4 filing?
Kemula Pierre Thadee Victor's most recent SEC Form 4 filing on Tracefour is dated Oct 7, 2026.
What is Kemula Pierre Thadee Victor's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kemula Pierre Thadee Victor is listed as Chief Financial Officer.
What is Kemula Pierre Thadee Victor's total buy and sell value in the current window?
Inside the rolling retention window, Kemula Pierre Thadee Victor bought $86K and sold $0 based on SEC Form 4 filings.
What was Kemula Pierre Thadee Victor's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000 AGMB shares on 2026-10-06, worth $86K, per SEC Form 4 filings.